Remed Co.,Ltd. (KOSDAQ:302550)

Market Cap	98.28B -7.8%
Revenue (ttm)	24.26B +3.6%
Net Income	3.28B -32.6%
EPS	103.55 -34.8%
Shares Out	30.91M
PE Ratio	30.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	210,181
Average Volume	1,429,904
Open	3,150.00
Previous Close	3,175.00
Day's Range	3,090.00 - 3,275.00
52-Week Range	2,640.00 - 4,595.00
Beta	0.73
RSI	52.15
Earnings Date	Mar 18, 2026

About Remed

Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In a...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2003
• Employees: 92
• Stock Exchange: KOSDAQ
• Ticker Symbol: 302550

Financial Performance

In 2024, Remed's revenue was 25.55 billion, an increase of 37.86% compared to the previous year's 18.54 billion. Earnings were 7.17 billion, an increase of 799.69%.